|
|
HIV Update 2002 (12) - DecemberPublished by: Datamonitor Published: Apr. 28, 2003 - 12 Pages Table of ContentsEXECUTIVE SUMMARY Introduction Scope and coverage of the Brief ANALYSIS OF KEY DEVELOPMENTS IN DECEMBER 2002 COMPANY HEADLINES RESEARCH AND DEVELOPMENT HEADLINES DISEASE SPECIFIC HEADLINES EMERGING MARKETS HEADLINES APPENDIX Contacts and Further Reading Disclaimer AbstractIntroductionProvides an account of all the key market events that took place during December 2002. Key events include new product launches, clinical trial data and conference findings. Key events are analyzed in the HIV market during December. Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors. Future of HIV therapy lies in simplification of drug regimens. Scope Key events are analyzed in the HIV market during December 2002 Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors. Report Highlights Focus on the emerging markets and the effect on the pharmaceutical industry Analysis of novel pipeline drug profiles and clinical data Reasons to Purchase Stay informed of all of the important market led events taking place in the HIV market Gain insight into the likely market impact of the events that took place in October 2002 in the HIV market Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||